Immune Therapeutics Insider Trades

IMUN

Track insider trading activity from Immune Therapeutics executives and directors. See which insiders are buying and selling IMUN stock.

Trades Last 12 Months

All Insider Trades for Immune Therapeutics

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Farmer Glen A Chief Financial Officer
Holding Value $38k 409,000 shares
Last Trade
Feb 10, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.09
Global Reverb Corp 10% owner
Holding Value $0 0 shares
Last Trade
Mar 31, 2019 Sale
No data
No data
$0.09
Pearce Christopher CHIEF OPERATING OFFICER
Holding Value $267k 2,876,125 shares
Last Trade
Jul 18, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.09
Akin Paul Director
Holding Value $209k 2,250,000 shares
Last Trade
Jul 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.09
Aronstam Peter Chief Financial Officer
Holding Value $39.5k 425,000 shares
Last Trade
Jun 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.09
Selsky Clifford Director
Holding Value $23.3k 250,000 shares
Last Trade
Apr 08, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.09
Holding Value $0 0 shares
Last Trade
Feb 16, 2016 Sale
No data
No data
$0.09
Elliott Seth President/ COO
Holding Value $116k 1,250,000 shares
Last Trade
Jan 13, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.09
Shaw Seth M Chief Executive Officer
Holding Value $935k 10,053,800 shares
Last Trade
May 13, 2013 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up